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Renal vasodilation and uncoupling of blood flow and filtration
rate autoregulation. Renal vasodilation experiments were con-
ducted in dogs to examine the mechanism by which the kidney
continues to autoregulate glomerular filtration rate during
decreased blood flow autoregulatory efficiency. Following intra-
arterial infusions of acetylcholine, dopamine, papaverine or
prostaglandin E2 (POE2), renal blood flow increased by 40 to
100%, intrarenal venous pressure increased by 45 to 120%, and
urine flow increased up to fivefold. OFR was not altered signifi-
cantly except for a decrease observed during papaverine infusion.
The magnitude of the diuretic responses was not directly related
to either the increase in renal blood flow or the increase in intra-
renal venous pressure. Blood flow autoregulatory efficiency
during reductions in arterial pressure was decreased to a variable
extent and most markedly with acetylcholine. Efficiency of OFR
autoregulation was well maintained during vasodilation with
acetylcholine, dopamine and POE2. Intrarenal venous pressure
and glomerular pressure (computed on the basis of minimal pre-
glomerular resistance measurements) were elevated during vaso-
dilation and became more responsive to changes in arterial
pressure. The results indicate that while renal vasodilation de-
creases both pre- and post-glomerular resistances, a net increase
in glomerular pressure occurs. The increase in intrarenal venous
pressure suggests that proximal tubular pressure increases to
offset the increased glomerular pressure. The concomitant
changes in intrarenal venous pressure and glomerular pressure
during reductions in arterial pressure suggest further that main-
tenance of effective filtration pressure and thus OFR during
vasodilation may be effected by changes in proximal tubular
pressure associated with the changes in glomerular pressure.
Vasodilatation rénale et dissociation de l'autorégulation du
debit sanguin renal et du debit de filtration. Des experiences de
vasodilatation rénale ont été réalisées chez des chiens afin
d'étudier Ic mécanisme par lequel le rein continue a réguler le
debit de filtration glomérulaire alors que l'efficacité de Ia régula-
tion du debit sanguin est diminuée. Aprés Ia perfusion intra-
artérielle d'acetylcholine, de dopamine, de papavérine ou de
prostaglandine E2 (POE2), le debit sanguin renal a augmenté de
45 a 120% et Ic debit urinaire augmenté jusqu'à 5 fois. Le debit
de filtration glomérulaire n'a pas eté significativement modifié a
l'exception d'une diminution observee au cours de Ia perfusion
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de papavérine. Aucune correlation n'a pu être établie entre
l'importance de la réponse diurétique et l'augmentation du debit
sanguin renal d'une part et l'augmentation de Ia pression veineuse
intra-rénale d'autre part. L'efficacité de l'autorégulation du
debit sanguin renal en presence de diminutions de Ia pression
artérielle a été diminuée de façon variable, Ia diminution Ia plus
importante a été observée avec I'acetylcholine. L'efficacité de
l'autorégulation du debit de filtration glomérulaire a été bien
maintenue au cours de Ia vasodilatation par l'acetylcholine, Ia
dopamine et le POE2. La pression veineuse intra-rénale et Ia
pression glomérulaire (calculees a partir de mesures de Ia ré-
sistance pre-glomérulaire minimale) ont eté plus influencées par
les variations de Ia pression artérielle dans les situations de vaso-
dilatation. Le résultat de ces experiences indique qu'alors que
Ia vasodilatation rénale diminue a Ia fois les resistances pré et
post glomérulaires la pression glomérulaire augmente. L'augmen-
tation de Ia pression veineuse intra-rénale suggére que Ia pression
tubulaire proximale augmente pour compenser I'augmentation
de Ia pression glomérulaire. Les modifications concomitantes de
Ia pression veineuse intra-rénale et de Ia pression glomerulaire
au cours des reductions de Ia pression artérielle indiquent que
le maintien d'une pression effective de filtration, et donc du debit
de filtration glomérulaire, au cours de Ia vasodilatation est
effectué par une modification de Ia pression tubulaire proximale
associée aux changements de Ia pression glomérulaire.
Recent reports have shown that most vasodilating agents,
when infused into the renal artery, do not alter the gb-
merular filtration rate (OFR) although the total resistance
to renal blood flow (RBF) is reduced [1—6]. In contrast,
papaverine is reported to cause a decrease in OFR [1, 7, 8]
while some investigators [9] report that it is increased by
dopamine. Also, it has been demonstrated that the ca-
pability to autoregulate the GFR in response to reductions
in arterial pressure can continue undiminished [1, 10] despite
a greatly reduced ability to autoregulate RBF, although
the abolition of OFR autoregulation can sometimes occur
during acetylcholine infusion [11].
Although GFR is not usually elevated with vasodilation,
urine flow and electrolyte excretion are markedly increased
[1—5, 8, 12—14], and become more sensitive to changes in
renal arterial pressure [1, 10, 15]. The responsible mechanism
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for the reduction in net tubular fluid reabsorption remains
incompletely understood. Some investigators have sug-
gested a direct effect of certain vasodilators to inhibit
transport of sodium and water out of the tubules or to
alter permeability and thus allow increased backflux from
interstitium to tubule lumen [2, 8, 13, 16, 17]. Others
suggest that the decrease in reabsorption is secondary to
changes in the net Starling forces which govern uptake by
the peritubular capillaries; as a result, there occurs an
elevation of pressure subsequent to reduced resistance to
blood flow and/or a reduced peritubular capillary colloid
osmotic pressure resulting from the decreased filtration
fraction [1, 3, 12, 18, 19]. Accompanying the elevation in
peritubular capillary blood pressure is an increase in
proximal tubular fluid pressure [20, 21] and an increase in
renal lymph formation [22] which indicates an increased
renal interstitial pressure.
It has sometimes been assumed that the absence of a
change in GFR also indicates an absence of a change in
glomerular pressure; consequently, vasodilators that do
not alter GFR have been considered to cause appropriate
alterations in both afferent and efferent arteriolar resistance
such that glomerular pressure stays constant [5, 11, 14].
However, the reports showing that proximal tubular pres-
sure is also affected by vasodilators [20, 21] necessitate a
more stringent evaluation of changes in segmental re-
sistances in response to vasodilators.
The mechanism by which GER continues to be auto-
regulated during vasodilation while RBF becomes a nearly
passive function of arterial pressure is not apparent. In
normal conditions, constancy of both GFR and RBF
during changes in renal perfusion pressure has been thought
to be achieved by alterations in resistance of the afferent
arterioles [20, 23]. According to this concept, GFR is auto-
regulated because glomerular pressure is also maintained
relatively constant during changes in arterial pressure.
However, because of our previous finding that the two
autoregulatory phenomena can be uncoupled during vaso-
dilation [1], it was deemed necessary to re-examine the
possible mechanisms of GFR autoregulation during both
normal and vasodilated states. A technique based on the
concept of minimal pre-glomerular resistance as previously
presented [23] has been utilized to evaluate segmental
vascular resistances and to estimate mean glomerular pres-
sure at several arterial pressures in control states and during
vasodilation. In addition, these studies have allowed a
comparison of the relative effects of the various vaso-
dilators on renal blood flow, intrarenal venous pressure,
and urine flow; thus, they are germane to the mechanism
of vasodilator diuresis. Finally, the nature of this study
allows an evaluation of the possible role of filtration equi-
librium in the regulation of glomerular dynamics in the dog.
Methods
Experimental preparation. Experiments were performed
on 18 dogs weighing 17 to 30 kg and anesthetized with
30 mg/kg sodium pentobarbital. The right femoral artery
and left jugular vein were catheterized to permit measure-
ment of aortic blood pressure, sampling of arterial blood,
and infusion of solutions. A tracheotomy was performed
and artificial respiration was maintained when necessary.
As previously described [1, 23], the left renal artery and
vein, ureter, and gonadal vein were freed from surrounding
tissue through a left flank incision. The ureter was cathe-
terized and timed urine samples were collected in calibrated
tubes. The gonadal vein was catheterized with an 18-gauge
Teflon needle catheter which was advanced to the renal vein
to permit collection of renal venous blood. A 15-gauge
needle was passed through the dorsal body wall to permit
retrograde catheterization of the renal vein with a 20-gauge
Teflon needle catheter. This catheter was advanced until a
sudden rise in pressure and the appearance of pressure
pulsations indicated that it had entered the region of the
junction of the interlobar and arcuate veins [23, 24]. The
catheter was attached to a Statham pressure transducer for
measurement of intrarenal venous pressure (IVP).
A flow transducer was placed on the renal artery ad-
jacent to the aorta to monitor RBF with a Carolina Medical
Electronics square-wave electromagnetic flowmeter. Distal
to the transducer, a plastic and adjustable occluder was
placed on the artery so that renal arterial pressure (RAP)
could be set at any level equal to or below aortic pressure.
It the artery was too short to accommodate the occluder,
an adjustable clamp was placed on the aorta between the
left and right renal arteries. After determination of normal
RBF, a 20-gauge Teflon needle catheter, connected to a
Harvard syringe pump and to a Statham pressure trans-
ducer, was inserted into the renal artery distal to the
occluder to permit measurement of RAP and infusion into
the renal artery. Isotonic saline was continuously infused
at 0.2 mI/mm through this catheter to prevent clotting.
After collection of control urine and blood samples,
a priming dose of polyfructosan (mutest, Laevosan-Gesell-
schaft, Austria) was given, followed by a continuous in-
fusion to establish appropriate plasma levels for determina-
tion of GFR. A 40-minute equilibration period was allowed
before collecting samples.
Experimental protocol. I) Control measurements. Renal
arterial pressure was decreased by adjusting the occiuder
from control aortic pressure to 30 mm Hg in steps of 15 to
20 mm Hg. At each RAP level, adequate time was allowed
for blood flow autoregulation to occur. Arterial and renal
venous blood samples were collected, and RAP, IVP and
RBF were recorded. The renal artery was totally occluded
for 10 seconds after measurements were taken at 30 mm Hg
to determine the zero blood flow reference level. The oc-
cluder was then released and 10 to 15 mm were allowed for
re-establishment of control conditions.
2) Measurements during vasodilation. The renal arterial
saline infusion was replaced by an isotonic saline solution
containing one of the following: acetyleholine chloride
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(Matheson, Coleman and Bell), infused at a rate of 0.25 mgi
mm in a volume of 0.1 mI/mm (4 dogs); papaverine HCI
(Eli Lilly and Co.), infused at a rate of 6 mg/mm in a
volume of 0.2 mI/mm (4 dogs); dopamine (3-hydroxy-
tyramine HCI, Sigma Chemical Co.), infused at a rate of
1 to 1.5 J.Lg/kg/min in a volume of 0.1 mI/mm (5 dogs);
prostaglandin (PGE2, courtesy of Dr. J. Pike, The Up-
john Co.), infused at a rate of 1.0 jig/kg/mm in a volume
of 0.1 mI/mm (5 dogs).
After a maximum increase in RBF had been achieved,
urine samples and arterial and renal venous blood samples
were collected and RAP, IVP and RBF were recorded. The
occluder was then adjusted to decrease RAP in steps of
15 to 20 mm Hg, and sampling and measuring procedures
were repeated at each RAP level. After the zero RBF re-
ference check, the occluder was released, vasodilator in-
fusion was replaced by saline, and a period of 20 to 40 mm
was allowed for original control values to be achieved.
Recovery was usually quite good except for the experiments
in which papaverine was infused.
3) Urine flow measurements. Following recovery from
control measurements, and prior to infusion of vasodilator,
two to four timed urine samples were collected. The infusion
of vasodilator was begun immediately thereafter, and a
second set of two to four urine samples was collected after
RBF and urine flow reached steady levels. Urine flow
measurements were not included in the study if vasodilator
infusion caused arterial pressure to decrease more than
10 mm Hg below control. Since urine samples were not
quantitatively collected during renal arterial constriction,
this portion of the study is restricted to the response of
urine flow to vasodilation at control arterial pressures.
4) Ureteral occlusion. Following recovery of the prepara-
tion from vasodilator infusion, diuresis was produced by
rapid infusion of 350 ml of an isotonic mannitol solution
(6.0 g/100 ml) followed by sustaining infusion at 2 to
3 mi/mm. The ureteral catheter was attached to a T-tube
connected to a long vertical catheter and a Statham pres-
sure transducer. This allowed formation of urine up the
vertical catheter until sufficient hydrostatic pressure was
generated to stop urine flow. This maximum ureteral pres-
sure was measured, arterial and renal venous blood
samples were collected, and RBF, IVP and RAP were
recorded.
The renal arterial infusion of saline was then replaced
by the vasodilator solution used earlier in the experiment.
This was infused at the prior rate for a period of time equal
to that required to produce a maximal response in the
nonoccluded preparation. Measurements of ureteral pres-
sure, RBF, IVP and RAP were repeated.
5) Instrument calibration. Following completion of the
ureteral occlusion measurements, the renal artery was
catheterized without disturbing the flow transducer. Timed
blood flow collections were measured in a graduated
cylinder to determine the sensitivity of the flow transducer.
Upon termination of the calibration, the kidney was ex-
cised, drained and weighed.
Statham pressure transducers were periodically calibrated
against a mercury manometer and checked against each
other.
Analysis of samples. Plasma concentrations of poly-
fructosan were determined using an automated anthrone
method [1, 23]. Colloid osmotic pressure of arterial blood
was measured by a direct method using a membrane osmo-
meter mounted on a Statham pressure transducer [23].
Hematocrits were obtained with microhematocrit capillary
tubes. Renal plasma flow was (RPF) calculated from the
RBF as determined by the electromagnetic flowmeter
according to the formula:
RPF=RBFX(l —Hct) (I)
mutest (In) extraction data were utilized for the measure-
ment of GFR according to the formula:
GFR=RPFX(Ina—Inv)/Ina (2)
where ma and In are the arterial and renal venous mutest
concentrations. The advantages of this method for de-
termining GFR have been discussed in some detail pre-
viously [23, 25].
Analysis of data. To provide more uniform results, RBF,
GFR and urine flow were expressed as ml/min/g of
kidney wt. Intrarenal resistance (IRR) was calculated from
the formula:
RAP— IVPIRR= RBF (3)
The resistance terms have the units mm Hg/(ml/min .g)
and hereafter will be designated resistance units (RU).
Minimal IRR (IRRm) was defined as the resistance at a
RAP (50 to 60mm Hg) just below the autoregulatory range.
Changes in IRR were considered to be primarily due to
active response of the smooth muscles of the pre- and post-
glomerular vessels, while changes in venous resistance (VR)
calculated as:
'VPVR = (4)
were considered to result primarily from passive factors.
During the stop-flow phase of the experiment, the presence
of a negligible arteriovenous concentration difference for
mutest was taken as evidence that GFR was at or very
near zero. Under this condition, as has previously been
discussed [23], it was assumed that the sum of the plasma
colloid osmotic pressure and the maximal ureteral pressure
was equal to glomerular pressure (GPSf). It should be
emphasized that this value for GP is not to be considered
as an estimate of normal GP. It has been shown previously
that this condition produces a low level of afferent re-
sistance, termed the minimal afferent resistance (ARm) and
calculated as:
RAP—GP
ARm = RBF (5)
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By infusing vasodilators during this stop-flow phase, it was
possible to determine whether this maneuver caused any
additional decrease in JRR and AR.
The unique advantage of obtaining a value for minimal
afferent resistance is related to the calculation of changes in
segmental renal resistances during changes in RAP. For
any level of RAP, the afferent resistance (AR) was cal-
culated by obtaining the difference between the IRR for
that arterial pressure and IRRm, and adding this difference
to ARm:
AR=(IRRIRRm)+ARm.
Glomerular pressure was obtained by calculating the pres-
sure drop across the pre-glomerular vessels (AR x RBF)
and subtracting this value from RAP.
GP=RAP—(AR x RBF).
After arriving at a value for UP, efferent resistance (ER)
was calculated:
GP— IYPER= RBF—GFC (8)
These calculations were incorporated into a PDP-9 digital
computer program and data from individual experiments
at several RAP levels were analyzed during control con-
ditions and during vasodilator infusion. In addition the
same calculations were done on four "idealized" experi-
ments reconstructed from the mean data of the four dif-
ferent experimental groups. Treatment of the data in this
manner made it possible to estimate the effects of the
vasodilators on the afferent arteriolar and efferent arte-
riolar resistance segments, as well as on IRR. In addition,
we were able to evaluate the changes in glomerular pressure
occurring during RAP changes under control conditions
and during infusion of vasodilators. By using the intrarenal
venous pressure as an estimate of peritubular capillary
pressure, the effects of changes in arterial pressure alone or
in conjunction with vasodilator infusion on the venous
resistance component were also evaluated.
Results
Renal blood flow. The response of RBF to changes in
RAP during control conditions and infusion of the four
vasodilators is shown in Fig. 1. These mean curves were
constructed as follows: from the control arterial pressure—
blood flow relationship of each experiment, the RBF at
100 mm Hg RAP was determined and designated control
RBF (RBFC). Other blood flows during the control and
vasodilated states were then expressed as a percent of
RBFC. The average RBFC is also shown in Fig. 1 and is the
composite from the mean values of the four groups. As
evident from Fig. 1, all four agents caused substantial in-
creases in RBF varying from 40% to 100% above control,
and RBF was elevated over the entire arterial pressure
range examined. However, the effects on RBF autoregu-
latory efficiency were variable with the dopamine infusions
20 40 6080 100 120 140 160
Renal arterial pressure, mm Hg
Fig. 1. Effect of changes in renal arterial pressure on renal blood
' ' flow in the control state and during infusion of vasodilators. The
curves are labelled according to vasodilator being used (C = con-
trol, D = dopamine, P = papaverine,PG = POE2, A = acetyl-
choline) and standard errors are designated. Overall control
RBF at 100mm Hg is given.
20 40 60 80 100 120 140 160
Renal arterial pressure, mm Hg
Fig. 2. Relationships between renal arterial pressure and GFR in
control conditions (.) and during infusion of dopamine (•),
papaverine (a), PGE2 (a) and acetylcholine (o). Control GFR
at 100 mm Hg is shown and other values are expressed as % of
control.
decreasing autoregulatory capability only slightly and the
acetylcholine infusions resulting in a pressure-flow relation-
ship most indicative of a passive vascular bed.
Glomerular filtration rate. The responses of GFR to
changes in RAP during control conditions and during
infusion of vasodilators are shown in Fig. 2. The normalized
curves were constructed in the same manner as described
for the blood flow curves. The mean RAP-GFR relation-
ship also demonstrated excellent autoregulatory efficiency
with values ranging from 96% of GFRC at 90 mm Hg to
107% of GFRC at 130mm Hg. With decreases in RAP to
70 mm Hg, GFR had decreased to 80% and propor-
tionately to a greater extent than the RBF as has been
described [II]. At an arterial pressure of 50mm Hg, GFR
had decreased only to 47% of GFRC.
The responses of GFR to vasodilator infusion con-
trasted markedly with that of RBF in that a significant
200
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20 40 60 80 100 120 140
Renal arterial pressure, mm Hg
Fig. 3. Changes in intrarenal resistance in response to gradated
reductions in renal arterial pressure during control periods and
during infusions of vasodilators. Curves designated as in Fig. I.
increase in GFR was not observed with any of the vaso-
dilators. Additionally, despite the fact that there were
substantial differences in RBF autoregulatory efficiency
during vasodilator infusion, the RAP—GFR relationship
was essentially unchanged from the control relationship
during infusions of acetyicholine, dopamine and PGE2.
Papaverine infusion decreased GFR to approximately 60%
GFR0 as previously documented [11. The use of this agent
was associated with a greater degree of variability in the
data and the decrease in GFR was not generally reversible.
For that reason, only a single pooled data point is presented.
Intrarenal and venous resistance. Fig. 3 depicts the effects
of alteration in RAP on IRR during control conditions and
during vasodilator infusions. The normalized curves were
again constructed as previously described. The control
relationship demonstrates that as RAP was lowered, IRR
decreased from 134% IRRç at 130mm Hg down to a mini-
mal value of 62% of IRRC at a RAP of 50 mm Hg. During
infusion of each vasodilator, IRR was reduced to values
significantly lower than those in the control relationship
over the entire RAP range evaluated. The lowering of
minimal IRR at 50 mm Hg below the control IRRm is
considered to result primarily from efferent or post-
glomerular vasodilation. Dopamine and papaverine de-
creased this value to approximately 50% of IRRC while
prostaglandin and acetylcholine decreased IRRm to ap-
proximately 40% of IRRC. It can also be observed that
despite the vasodilator infusion, some adjustment of IRR
still occurred in response to reductions in RAP. Of the four
vasodilators used, acetyicholine was most effective in re-
ducing IRR to near minimal levels even at the higher levels
of RAP.
20 40 60 80 100 120 140
Renal arterial pressure, mm Jig
Fig. 4. Relationships between renal arterial pressure and intrarenal
venous pressure obtained in control conditions and during infusion
of designated vasodilators.
Venous resistance alterations during the control and vaso-
dilated phases of the study were generally quite slight and
neither the infusion of vasodilators nor reductions in RAP
resulted in significant changes in venous resistance. At a
RAP of 130 mm Hg, venous resistance was 4.6 SD0.7 RU
during the control phases and was 4.4 SD 0.9 RU during
the vasodilated phase. There were no perceptible differences
in the venous resistance responses to the various vaso-
dilators. With decreases in arterial pressure, venous re-
sistance decreased slightly during both the control and
vasodilated phases.
Intrarenal venous pressure and urine flow. The changes
in response to decreases in RAP during the control phase
and during vasodilation are shown in Fig. 4. At pressures
within the autoregulatory range, the control curve exhibits
a very slight slope. The slope becomes steeper at the lower
arterial pressures. The relationships obtained during vaso-
dilator infusion contrasted in that the IVP values at the
higher arterial pressures were increased and the curves
approached a more linear configuration. As can be seen,
papaverine, dopamine and PGE2 produced similar effects
and acetylcholine produced even greater increases in IVP.
All of the vasodilators caused both an increase in IVP
and a diuresis. IVP increased from 16±2 to 25±3mm Hg
while urine flow increased from 1.1 to 3.9±1 ml/min/
100 g kidney wt. When the individual effects of the vaso-
dilators were considered, it was apparent that the responses
were quantitatively different, and no consistent propor-
tionality was observed between changes in urine flow and
changes in IVP due to vasodilator infusion. Fig. 5 dem-
onstrates that while dopamine and prostaglandin caused
similar increases in IVP, urine flow was increased to 145%
and 556% of their control values. In contrast, acetyicholine
caused an increase of IVP to over 200% of control and the
urine flow increased to 475 % of control, a response similar
to that caused by papaverine and PGE. In addition, com-
parisons between the diuretic responses and the hyperemic
responses also demonstrated that the magnitude of the
diuretic response could not be quantitatively accounted for
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Fig. 5. Comparison of the effects of various vasodilators on intra-
renal venous pressure and urine flow. For each series of experi-
ments, the relative increase in IVP is plotted against the relative
increase in urine flow.
by the magnitude of the hemodynamic responses. Further-
more, while papaverine and acetyicholine caused similar
degrees of diuresis, acetylcholine caused a greater increase in
RBF and papaverine actually caused a decrease in GFR.
Ureteral obstruction and vasodilator infusion. The third
phase of the experiments consisted of administration of a
mild isotonic mannitol load followed by ureteral obstruc-
tion. The hemodynamic responses were observed when the
maximal ureteral pressure had been achieved and arterio-
venous inulin concentration differences were obtained to
insure that GFR was negligible. To determine if the vaso-
dilators could further decrease the minimal pre-glomerular
resistance, the intra-arterial infusions were also repeated
during maximal ureteral pressure phases. Table 1 presents
the mean values for measured hemodynamic variables and
also the resultant calculated values for intrarenal resistance,
glomerular pressure, pre-glomerular resistance, and venous
resistance. Ureteral occlusion resulted in an increased
RBF in all experiments. The calculated glomerular pressure
values obtained during maximal ureteral pressure were
taken as evidence that pre-glomerular vasodilation was a
consistent response of acute ureteral obstruction [25]. The
resultant calculated values for minimal preglomerular
resistance were, with the exception of the papaverine series,
in agreement with values previously obtained [23]. Also,
the calculated values for venous resistance during ureteral
obstruction were increased two to threefold above the
values obtained during the nonobstructed phases. The
relatively high value for minimal pre-glomerular resistance
obtained in the papaverine series even before re-infusion of
the vasodilator indicated that the infusion of papaverine
infusion might be associated with certain effects which were
not immediately reversible. This finding indicated that
calculations based on the papaverine series might not be
valid and, for that reason, will not be presented.
The infusion of vasodilators during the obstructed phase
resulted in a further slight decrease in intrarenal resistance
in all but the dopamine series. For the most part, the
additional vasodilation did not occur at pre-glomerular
sites. It should be emphasized that this third phase of the
experiments was conducted to obtain a value for minimal
preglomerular resistance which could then be used in
conjunction with data from the control and vasodilated
experiments to calculate pre- and postglomerular segmental
resistances and mean glomerular pressure.
Table 1. Hemodynamic data from stop flow phase before and during vasodilator infusion
Observation
Prostaglandin
C V
Acetyicholine Dopamine
C V
Papaverine
C V C V
Renal arterial pressure, mmHg 142±8 140±10 123±9 112± 18 132± 18 132± 18 135± 14 129± 11
Renal blood flow, mi/mm . g 4.9± 1.4 5.4± 1.6 4.9± 1.3 4.7± 1.0 4.6± 1.6 4.7± 1.6 3.9± 1.5 4.3± 1.6
Intrarenal venous pressure, mmHg 64±18 65±20 49±14 48±17 53±25 55±23 46±19 48±17
Ureteral pressure, mm Hg 105 7 103 6 86 9 82 9 89 21 87 23 89 14 84 16
• mmHgIntrarenal resistance,
ml/(mzn.g) 17.3 9.1 14.9± 3.6 15.8± 2.4 14.4± 2.8 17.9 + 2.2 17.0+ 1.8 22.8 + 2.6 19.0+ 1.3
Plasma oncotic pressure, mm Hg 20 4 20 4 14 2 14 2 19 3 19 3 17 3 17 3
Glomerular pressure, mm Hg 125 123 100 96 108 106 106 101
mm Hg
Preglomerular resistance, .
ml/(min .g) 3.5 3.1 4.7 3.4 5.2 5.5
7.4 6.5
mmHg
Venous resistance, .
ml/(mmn .g) 13.1 12.0 10 10.2 11.5 11.7
11.8 11.2
0
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Fig. 6. Effects on pre-glomerular resistance of reductions in arte-
rial pressure in control state and during infusion of vasodilators.
Estimation of glomerular pressure and segmental resist-
ances. The data from control and dilated phases of the
experiments were grouped according to the vasodilator
infused. For each group, mean values were calculated for
RBF, GFR and IVP at RAP between 130 and 50 mm Hg.
Using these mean values and those for minimal pre-
glomerular resistance, group mean values were computed
for afferent and efferent arteriolar resistances and gb-
merular capillary pressure as affected by reductions in RAP
during control phases and during infusion of vasodilators.
Values during vasodilation were normalized so that com-
parisons could be made against a single set of control values
obtained from joint analysis of the control data from all
experiments.
Using this technique, the observed relationships between
RAP and pre-glomerular resistance during control and
vasodilated conditions are shown in Fig. 6. The control
curve shows the expected relationship with marked de-
creases in resistance, within the autoregulatory range and
approach of a minimal value at the lower pressures.
Dopamine and POE2, while causing substantial decreases
in resistance did not prevent some additional adjustments
in response to decreases in arterial pressure. However,
minimal values were reached at a slightly higher arterial
pressure. During acetylcholine infusion, preglomerular
resistance was lowered to the greatest extent and only slight
adjustments were possible with reductions in RAP. In
only this series was there evidence that the minimal pre-
glomerular resistance was additionally reduced in response
to the vasodilator.
All of the vasodilators caused decreases in efferent re-
sistance also. The mean value for efferent resistarce was
10.6 RU with the average from the acetylcholine series
being slightly lower (9.2 RU) and the average from the
dopamine series being slightly higher (12 RU). Dopamine
and POE2 produced the same relative effects on efferent
resistance, these values decreasing to 72% and 70% of their
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Fig. 7. Calculated mean glomerular capillary pressure responses
to reductions in renal arterial pressure during control state and
during infusion of dopamine, PGE2 and acetylcholine.
respective control values. Again, acetylcholine produced
the most marked effects with efferent resistance decreasing
to 52% of its control value.
Calculations of glomerular pressure indicated that the
net result of vasodilation was an increase in glomerular
pressure as shown in Fig. 7. Dopamine and POE2 caused
a moderate increase in glomerular pressure and did not
prevent some autoregulation of glomerular pressure in
response to reductions in arterial pressure. On the other
hand, these calculations indicated that acetylcholine in-
creased glomerular pressure rather markedly and, ad-
ditionally, there was little evidence of autoregulation of
glomerular pressure during reductions of arterial pressure.
The control curve, as previously shown [23], demon-
strated typical autoregulatory behavior and the overall
mean value for control glomerular pressure obtained in
this series of experiments was 55 mm Hg. At arterial pres-
sures below the autoregulatory range, both control and
vasodilated glomerular pressures were similar and de-
creased linearly with further decreases in arterial pressure.
Discussion
In these experiments, the marked renal hyperemia oc-
curring in response to vasodilator infusion was not asso-
ciated with an increase in OFR. With the exception of
papaverine, which caused a decreased GFR, there was no
significant alteration in GFR. In addition, while the effi-
ciency of RBF autoregulation in response to reductions
in blood pressure was variably reduced, GFR auto-
regulatory efficiency was not disturbed during infusions of
acetylcholine, dopamine and POE2. This uncoupling of
GFR and RBF autoregulation was most evident during
acetylcholine infusion. By utilizing the assumptions and
methods presented previously [23] and described in Meth-
ods, it was possible to estimate changes in gbomerular
pressure and segmental vascular resistance in response to
reductions in arterial pressure during control and vaso-
dilated states.
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Intrarenal resistance alterations during vasodilation. The
vasodilator-induced reduction in total renal resistance was
shared to some degree by both elements of the pre-venous
vasculature. Examination of changes of pre-glomerular
resistance, considered to be primarily responsible for the
normal autoregulatory adjustments of resistance, suggested
that PGE2 and dopamine partially reduced autoregulatory
capability while acetylcholine rendered this vascular seg-
ment least capable of responding to changes in arterial
pressure. However, during infusion of PGE2 and dopamine,
the afferent arteriolar resistance, while reduced throughout
the arterial pressure range over which renal autoregulation
occurs, continued to vary with changes of arterial pressure.
Thus, continuing autoregulation of RBF during vasodila-
tion was accomplished almost entirely by the residual auto-
regulatory capability of the afferent arteriolar segments.
Evidence was not found to support the possibility that
venous compression or alterations in venous resistance
contributed significantly to the maintenance of partial
renal blood flow autoregulatory ability during vasodilation.
Glomerular filtration during vasodilation. Previous studies
have shown that proximal tubular pressure is elevated
during vasodilator-induced renal hyperemia [20, 21].
Classically, the observed constancy of GFR implies main-
tenance of the effective filtration pressure and thus an
increase in glomerular pressure. The present results in-
dicate that during vasodilation induced by acetylcholine,
dopamine and PGE2, an increase in glomerular capillary
pressure was sufficient to offset the increased proximal
tubular pressure, as indirectly estimated from the intrarenal
venous pressure measurements. In fact, the calculated in-
creases in glomerular pressure actually exceeded the
measured increments in IVP, especially in the acetylcholine
series. These discrepancies do not warrant rigorous evalua-
tion because of the quantitative limitations on both the
glomerular pressure and the proximal tubular pressure
estimates. For example, this technique probably under-
estimates tubular pressure and might not completely reflect
changes in proximal tubular pressure. However, the direct
measurements of peritubular capillary pressure in the dog
obtained by Knox et al [26] are quite similar to the IYP
measurements obtained in this study. Thus it is probably
justifiable to conclude that these IVP measurements are
valid as an index of peritubular capillary pressure. Fig. 8
depicts the overall pressure and resistance profiles along the
renal vasculature calculated for control conditions, vaso-
dilated states and during ureteral obstruction. At an arterial
pressure of 110 mm Hg, the increases in IVP were similar
to the calculated increases in glomerular capillary pressure
in response to the vasodilator infusions. The effects of papa-
verine could not be evaluated with this technique since
valid measurements of minimal afferent resistance were not
possible. However, indirect calculations suggested that
papaverine produced the greatest relative decrease in
efferent resistance and this perhaps resulted in a decreased
or unchanged glomerular pressure.
Fig. 8. Analysis of pressure gradients and resistance elements
along the renal vascular bed during control, vasodilator, and
ureteral obstruction phases. For control and vasodilator phases,
data were selected at an arterial pressure of 110 mm Hg.
The continuing autoregulation of GFR during vaso-
dilation appears to be dissociated to some extent from
afferent arteriolar adjustments. If this were not so, it would
be anticipated that GFR autoregulation during dopamine
and PGE2 infusion, for example, would have been much
better than during acetyicholine infusion. The data, how-
ever, show that GFR autoregulatory efficiency was not
diminished during acetylcholine and was essentially the
same as during control conditions. At variance with these
results, Abe, Dixon and McNay [11] reported loss of GFR
autoregulatory behavior during acetylcholine administra-
tion. However the pattern obtained in that study suggested
that GFR and effective filtration pressure were reduced
below control levels following reduction of blood pressure.
In the present experiments, GFR was not reduced and
continued to exhibit autoregulation. An explanation for
this type of autoregulation may be based on the relationships
obtained between RAP and intrarenal venous pressure. In
the control phase, changes in RAP within the autoregulatory
range produced only slight changes in IVP. Presumably,
afferent resistance responses plus the higher level of efferent
resistance shielded the peritubular capillary network from
most of the change in arterial pressure. During vasodilation,
the absolute level of resistance across both segments was
reduced, as was the ability of the afferent segment to adjust
Resistance, mm Hg/mi per mm g
Afferent Efferent Venous
Control 16 11.6 4.3
Dopamine 10 8.2 4.1
Prostaglandin 7.6 8.0 3.4
Acetylcholine 6.4 6.1 4.7
Uret. obst. 4.1 11.7 11.6
(I,U,
2
Renal Glomerular Peritubular Renal
artery capillaries capillaries vein
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its resistance with changes in pressure. As a consequence,
IVP varied with arterial pressure to a greater extent and in
a relatively linear manner, just as it did in the control
phases at arterial pressures below 70 mm Hg. To the
extent that changes in IVP reflect changes in proximal
tubular pressure, the data indicate that changes in gb-
merular pressure during decreases in RAP in the vasodilated
state are accompanied by concomitant changes in proximal
tubular pressure. In the acetylcholine series, the changes in
estimated glomerular pressure were greater than the IVP
changes suggesting an increased effective filtration pressure
at the higher arterial pressures. Since GFR was not in-
creased, the possibility exists that proximal tubular pressure
increased more than intrarenal venous pressure, especially
at the higher pressures obtained with acetylcholine. Because
of these limitations, calculations of effective filtration pres-
sure were not considered quantitatively valid. Never-
theless, the data suggest that, under certain circumstances,
the steady-state effective filtration pressure can be main-
tained even in the face of a changing glomerular pressure
by accompanying changes in proximal tubular pressure. It is
not unlikely that such a mechanism could be responsible
for the continuing autoregulation of GFR that occurs in
the normal kidney as arterial pressure is increased to levels
above the upper limit for RBF autoregulation [27].
Certain aspects concerning the classical concepts [28]
related to the nature of glomerular filtration have recently
been re-evaluated [29, 30]. In essence, findings of a relatively
high filtration fraction and a relatively low glomerular
hydrostatic pressure in superficial nephrons of the rat
kidney have been interpreted as indicating that filtration
equilibrium is normally achieved in the glomerulus. This
equilibrium process is thought to occur early within the
glomerular capillaries, so that changes in the point at which
filtration equilibrium occurs could conceivably play a role
in regulating filtration rate. An important prediction of this
hypothesis is that an increase in renal plasma flow should
be associated with an increase in GFR even if glomerular
pressure and effective filtration pressure do not increase.
This plasma flow dependence of GFR has been demon-
strated in the rat [31]. In the dog, indirect calculations based
on stop-flow techniques [23] or molecular sieving analysis
[32] have suggested that glomerular pressure in hydropenic
conditions is not as low as in the rat. If so, when coupled
with recent measurements of superficial efferent protein
concentrations [17, 33} in the dog, it would appear that
filtration equilibrium does not obtain in the dog, at least
during normal hydration and antidiuresis. The present
results bear on this point in that marked vasodilation-
associated increases in renal plasma flow were not attended
by parallel increases in GFR. Also, GFR was not dependent
on plasma flow when RAP was reduced and there was no
indication that effective filtration pressure was lower
during vasodilation than during control conditions. There-
fore, the results of this study are interpreted as providing
evidence that the process of filtration equilibrium probably
does not play a significant role in the control of overall
dynamics of glomerular filtration in the dog.
Mechanics of vasodilator diuresis. The central focus of
this work was not on the effects of vasodilation on urine
flow. However, some of the observed hemodynamic
responses bear upon the diuretic response. It is evident
that the increase in urine flow is due to decreased tubular
fluid reabsorption since diuresis occurred whether GFR
was decreased or unchanged. Also, RBF elevation per se
was not directly associated with the magnitude of diuresis
since dopamine increased urine flow only slightly although
it increased RBF and intrarenal venous pressure almost as
much as papaverine. Other hemodynamic effects were
similarly unrelated when examined quantitatively. Acetyl-
choline produced a much greater increase in intrarenal
venous pressure than the other vasodilators, but its diuretic
effect was intermediate to that of papaverine and POE2.
In addition, because acetylcholine increased blood flow
more than POE2 did, filtration fraction was decreased more
by infusion of acetylcholine. Therefore, blood entering the
peritubular capillary reabsorptive network would have a
lower initial colloid osmotic pressure. Both the greater
increase in IVP and the lower initial colloid osmotic pressure
in the peritubular capillary during acetylcholine infusion
should have produced a diuresis greater than that produced
by POE2, if alterations in Starling forces governing pen-
tubular capillary uptake are the major determinants of
decreased reabsorption during vasodilation. The diuresis
was essentially the same. In essence, comparison of the
relative hemodynamic and diuretic responses to the various
vasodilators lends support to the conclusions of other
investigators [2, 8, 13, 16, 17, 34, 35]. Thus while changes in
Starling forces may play an important role in mediating the
diuretic response, an important variable most likely related
to the magnitude of the diuresis is the relative direct effect
on reabsorptive mechanisms or tubular permeability.
In conclusion, these experiments suggest that while both
pre- and post-glomerular resistances are reduced by vaso-
dilation, net decreases in pre-gbomerular resistance usually
predominate and gbomerular pressure thus increases. Con-
sequently, maintenance of GFR appears to be due, in large
measure, to the augmented proximal tubular pressure
measured directly by others [20, 211 as indicated by intra-
renal venous pressure measurements in this study. With
changes in arterial pressure, GFR is normally auto-
regulated along with renal blood flow and glomerular
pressure through adjustments in pre-glomerular resistance.
However, during vasodilation, GFR and effective filtration
pressure may continue to be autoregulated even in the
absence of renal blood flow autoregulation, and it appears
that this is effected through concomitant changes in gb-
merular and proximal tubular pressures.
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